Latest

psychopharmacology

This shows a diagram of how the drug works

Featured Neuroscience Psychology

·June 3, 2019·3 min read

Diabetes drug alleviates anxiety in mice

Metformin, a common diabetes medication, shows promise for the treatment of anxiety and depression.

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·May 21, 2019·5 min read

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

Esketamine combined with antidepressants acts rapidly to help alleviate symptoms in those with treatment-resistant depression.

Featured Neuroscience Psychology

·May 16, 2019·5 min read

Ketamine: The illicit party psychedelic that promises to heal depression

Ketamine, an anesthetics which has been commonly used as an illicit party drug, is helping people overcome depression. The drug works rapidly and provides lasting relief from depressive symptoms for weeks after exposure. Researchers are examining how ketamine works in the brain to help positively influence behavior in those with mood disorders.

This shows a blue head and an orange head

Featured Neuroscience Psychology

·April 24, 2019·4 min read

CBD reduces impairment caused by cannabis

Cannabidiol may buffer the effects of THC on the brain for those who use marijuana. Marijuana with a higher CBD content restores disruptions to the salience network caused by THC exposure.

Featured Neuroscience Psychology

·April 23, 2019·2 min read

Texas A&M Research Leads To First Drug For Postpartum Depression

A newly developed drug can help combat the effects of postnatal depression.

This shows how NV-5138 affects dendrites

Featured Neuroscience Open Neuroscience Articles Psychology

·April 17, 2019·3 min read

New drug mimics benefits of ketamine for depression

NV-5138, a small molecule drug that mimics the action of ketamine, provides fast-acting antidepressant responses in rodent models of depression. The drug is currently undergoing Phase 1 testing in humans.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 11, 2019·3 min read

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

The formation of prefrontal cortex dendritic spine formation sustains the remission of depressive related symptoms and behaviors following ketamine treatment by restoring lost spines.

This image shows a lot of brightly colored pills

Featured Neuroscience Open Neuroscience Articles Psychology

·April 8, 2019·5 min read

Anti-inflammatory medicine can have a beneficial effect on depression

Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.

This shows a brain overlayed on a person's head with a swirly, psychedelic background

Featured Neuroscience Psychology

·April 4, 2019·5 min read

Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD

MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.